End-of-day quote
Other stock markets
|
||
- USD | - |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Novel Therapeutics
100.0
%
| 0 | nan % | 7 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 7 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jason Okazaki
CEO | Chief Executive Officer | 48 | 29/03/20 |
Anuj Gaggar
CTO | Chief Tech/Sci/R&D Officer | 46 | 11-07 |
William Delaney
CTO | Chief Tech/Sci/R&D Officer | 52 | 31/05/20 |
John McHutchison
BRD | Director/Board Member | 66 | 05/08/19 |
Shannon Ryan
IRC | Investor Relations Contact | - | - |
Comptroller/Controller/Auditor | - | 31/07/19 | |
General Counsel | - | 31/08/22 | |
Nicole White
PRN | Corporate Officer/Principal | 44 | 16/11/20 |
Human Resources Officer | - | 30/04/17 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Susan Mahony
BRD | Director/Board Member | 59 | 13/12/17 |
Gina Consylman
BRD | Director/Board Member | 52 | 19/10/20 |
William Ringo
CHM | Chairman | 78 | 30/06/14 |
Anthony Altig
BRD | Director/Board Member | 68 | 31/12/11 |
Jason Okazaki
CEO | Chief Executive Officer | 48 | 29/03/20 |
Michael Houghton
BRD | Director/Board Member | 73 | 18/07/21 |
John McHutchison
BRD | Director/Board Member | 66 | 05/08/19 |
Tomas Cihlar
BRD | Director/Board Member | 57 | 12-06 |
Director/Board Member | 60 | 19/05/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 5,513,308 | 3,690,474 ( 66.94 %) | 0 | 66.94 % |
Company contact information
Assembly Biosciences, Inc.
Two Tower Place 7th floor
94080, South San Francisco
+833 509 4583
http://www.assemblybio.comSector
1st Jan change | Capi. | |
---|---|---|
+9.85% | 72.5B | |
+13.02% | 9.11B | |
-12.85% | 5.07B | |
+60.16% | 5.01B | |
+1.60% | 3.85B | |
-19.20% | 2.46B | |
+18.65% | 2.44B | |
+24.62% | 2.27B | |
-27.46% | 2.26B |
- Stock Market
- Equities
- ASMB Stock
- Stock
- Company Ventrus Biosciences Inc